These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19339839)
21. Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange. Basquiera AL; Damonte JC; Abichaín P; Sturich AG; García JJ Ann Hematol; 2008 Apr; 87(4):321-3. PubMed ID: 17899079 [No Abstract] [Full Text] [Related]
22. Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: the role of interleukin-12 suppression? Park SJ; Shin JI Crit Care Med; 2012 Apr; 40(4):1391. PubMed ID: 22425862 [No Abstract] [Full Text] [Related]
23. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542 [TBL] [Abstract][Full Text] [Related]
24. Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide. Stein GY; Zeidman A; Fradin Z; Varon M; Cohen A; Mittelman M Int J Hematol; 2004 Jul; 80(1):94-6. PubMed ID: 15293577 [TBL] [Abstract][Full Text] [Related]
25. Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports. Dalia S; McNulty B; Colvin GA Med Health R I; 2008 Jul; 91(7):226-8. PubMed ID: 18705225 [No Abstract] [Full Text] [Related]
26. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus. Hundae A; Peskoe S; Grimsley E; Patel S South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978 [TBL] [Abstract][Full Text] [Related]
27. Intensive rituximab regimen in immune-mediated thrombotic thrombocytopenic purpura can circumvent unresponsiveness to standard rituximab treatment. Barba C; Peyre M; Galicier L; Cathebras P; Ranta D; Malot S; Veyradier A; Coppo P Br J Haematol; 2021 Jan; 192(1):e21-e25. PubMed ID: 33216951 [No Abstract] [Full Text] [Related]
28. Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure? Kyttaris VC Crit Care Med; 2012 Jan; 40(1):317-8. PubMed ID: 22179358 [No Abstract] [Full Text] [Related]
29. [Paediatric case report of an acquired autoimmune thrombotic thrombocytopenic purpura]. Curtillet C; Poullin P; Doré E; Fossat C; Lefevre P; Michel G Arch Pediatr; 2006 Dec; 13(12):1521-4. PubMed ID: 17010579 [TBL] [Abstract][Full Text] [Related]
30. Thrombotic thrombocytopaenic purpura occurring in consecutive pregnancies in an HIV-infected patient. Robertson C; Wiselka MJ Int J STD AIDS; 2007 Feb; 18(2):142-3. PubMed ID: 17331295 [TBL] [Abstract][Full Text] [Related]
31. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Ling HT; Field JJ; Blinder MA Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208 [TBL] [Abstract][Full Text] [Related]
32. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange. Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282 [TBL] [Abstract][Full Text] [Related]
33. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange]. Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471 [TBL] [Abstract][Full Text] [Related]
34. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR; Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259 [TBL] [Abstract][Full Text] [Related]
35. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange]. Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104 [TBL] [Abstract][Full Text] [Related]
37. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab. Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551 [No Abstract] [Full Text] [Related]
38. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)]. Illner N; Wolf G Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379 [TBL] [Abstract][Full Text] [Related]
39. [Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura]. Pérez A; Sancho JM; Grífols JR; Ribera JM Med Clin (Barc); 2011 Jun; 137(3):139-40. PubMed ID: 21074219 [No Abstract] [Full Text] [Related]
40. Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura. Stein GY; Blickstein D; Orlin J; Sarig G; Inbal A Isr Med Assoc J; 2011 Jul; 13(7):398-401. PubMed ID: 21838180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]